ICAD : Summary for icad inc. - Yahoo Finance

U.S. Markets open in 2 hrs 45 mins

iCAD, Inc. (ICAD)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.75-0.02 (-0.53%)
At close: 4:00PM EST
People also watch
IRIXICCCINODIDSYICUI
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.77
Open3.76
Bid2.24 x 100
Ask4.98 x 200
Day's Range3.59 - 3.89
52 Week Range2.82 - 6.49
Volume18,631
Avg. Volume33,422
Market Cap60.18M
Beta1.39
PE Ratio (TTM)-6.45
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks Small Cap Research12 days ago

    ICAD: Certain Catalysts Expected to Return ICAD to Positive Revenue Growth in 2017

    Certain Catalysts Expected to Return ICAD (ICAD) to Positive Revenue Growth in 20172016 has been a disappointing year in terms of revenue.  Therapy revenue through the first nine months of the year is down 66%, largely as a result of the unfavorable change to reimbursement of non-melanoma skin cancer.  Detection revenue has fared much better, but is still down over 13% over the same period and has been hampered by the loss of iCAD’s (ICAD) MRI distribution agreement (as of August 2015).  And delays to FDA clearance and U.S. launch of the 3D tomosynthesis product have also trimmed Detection revenue expectations for 2016. - 3D Tomosynthesis;  We think tomo could be a big winner for ICAD given the criticism and debate over the utility of stand-alone mammography and increased demand for more accurate detection of breast cancer.  Radiologists are regularly demanding system upgrades from 2D to 3D due to the latter’s proven ability to improve cancer detection rates, reduce recall rates, shorten reading time and lessen reading fatigue.  This has resulted in a swift transition to 3D tomosynthesis.  Armed with clinical studies demonstrating the benefits of 3D tomo, ICAD is looking to capitalize on this industry shift.

  • Accesswire3 months ago

    iCAD to Present at the 9th Annual LD Micro Main Event

    LOS ANGELES, CA / ACCESSWIRE / November 30, 2016 / iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification ...

  • PR Newswire3 months ago

    iCAD to Showcase Use of Artificial Intelligence in Medical Imaging at RSNA 2016

    NASHUA, N.H. and CHICAGO, Nov. 28, 2016 /PRNewswire/ -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early detection ...